White coat hypertension
Owens P, Lyons S, Rodriquez S, O’Brien E. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ damage?. J Human Hypertens 1998;12:743-748
Parati G, Omboni S, Staessen J, Thijs L, Fagard R, Ulian L, Mancia G on behalf of the Syst-Eur Investigators. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ’white-coat’ effect. J Hypertens 1998;16:23-29.
Den Hond E, Celis H, Vandenhoven G, O’Brien E, Staessen JA for the THOP investigators. Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure. Blood Pressure Monit 2003;8:37-40
Verdecchia P, O’Brien E, Pickering T, Staessen JA, Parati G, Myers M, Palatini P on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. When to suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens 2003;16:87-91
Grodzicki T, Rajzer M, Fagard R, O’Brien ET, Thijs L, Clement D, Davidsonf C, Palatini P, Parati G, Kocemba J, Staessen JA on behalf of the Systolic Hypertension In Europe (SYST-EUR) Trial Investigators. Ambulatory blood pressure monitoring and post-prandial hypotension in elderly patients with isolated systolic hypertension. J Human Hypertens 1998;12:161-165